Operating Properties of Disease Activity Indices in Pediatric Inflammatory Bowel Disease: A Systematic Review
Inflammatory Bowel Diseases · 2025
DOI: 10.1093/ibd/izae060 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Inflammatory Bowel Diseases, 2025. Verfasst von Ruben J Colman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Stanford University School of Medicine, USA. Hauptthemen laut MEDLINE: Severity of Illness Index, Crohn Disease, Colitis, Ulcerative. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
Background
Accurate, reliable, and responsive disease activity indices are important to streamline drug approval and treatment modalities for pediatric inflammatory bowel disease (pIBD). We aimed to identify all scoring indices used in pIBD randomized controlled trials (RCTs) and to evaluate their operating properties.
Methods
MEDLINE, EMBASE, and CENTRAL were searched on December 6, 2022, to identify studies evaluating clinical, endoscopic, imaging, or patient-reported outcome measures (PROMs) in pIBD including Crohn’s disease (CD) and ulcerative colitis (UC). Validity, reliability, responsiveness, and feasibility were summarized.
Results
Seventy RCTs evaluating pIBD indices were identified. Forty-one studies reported on the operating properties of 14 eligible indices (n = 9 CD, n = 5 UC). The Pediatric Crohn’s Disease Activity Index (PCDAI) varied widely in terms of validity and reliability and was less feasible overall. In contrast, the Mucosal Inflammation Noninvasive Index, which includes fecal calprotectin, had better operating properties than the PCDAI. The Simplified Endoscopic Mucosal Assessment of Crohn’s Disease appears more feasible and had similar operating properties than the longer Simple Endoscopic Score for Crohn’s Disease. The Pediatric Ulcerative Colitis Activity Index was feasible, valid, and reliable, but responsiveness needs to be evaluated further. The Endoscopic Mayo score and the Ulcerative Colitis Endoscopic Index of Severity were reliable, but validity and responsiveness need to be evaluated further. Imaging and PROMs/quality of life indices need further evaluation.
Conclusions
The operating properties of pIBD clinical trial end points varied widely. These results highlight the need for further validation and development of novel indices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Stanford University School of Medicine, USA.
- Department of Medicine, Division of Gastroenterology, Schulich School of Medicine, Western University, Canada.
- Gastroenterology and Endoscopy, IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milan, Italy.
- Alimentiv Inc, London, ON, Canada.
- Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary, Calgary, AB, Canada.
- Department of Community Health Sciences, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.
ORCID-Profile: Ruben J Colman, Virginia Solitano, Christopher Ma, Vipul Jairath, Eileen Crowley
Zitieren
APA
Colman, R. J., Solitano, V., MacDonald, J. K., Ma, C., Griffiths, A. M., Jairath, V., & Crowley, E. (2025). Operating Properties of Disease Activity Indices in Pediatric Inflammatory Bowel Disease: A Systematic Review. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izae060
Vancouver
Colman RJ, Solitano V, MacDonald JK, Ma C, Griffiths AM, Jairath V, et al. Operating Properties of Disease Activity Indices in Pediatric Inflammatory Bowel Disease: A Systematic Review. Inflammatory Bowel Diseases. 2025. doi:10.1093/ibd/izae060
BibTeX
@article{Colman2025,
author = {Colman, Ruben J and Solitano, Virginia and MacDonald, John K and Ma, Christopher and Griffiths, Anne M and Jairath, Vipul and Crowley, Eileen},
title = {Operating Properties of Disease Activity Indices in Pediatric Inflammatory Bowel Disease: A Systematic Review},
journal = {Inflammatory Bowel Diseases},
year = {2025},
doi = {10.1093/ibd/izae060}
}
EUVIMED